North America active pharmaceutical ingredients (API) market is expected to grow by 5.5% annually in the forecast period and reach $106.28 billion by 2027 owing to the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic.
Highlighted with 90 tables and 64 figures, this 161-page report “North America Active Pharmaceutical Ingredients (API) Market 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2020 and provides forecast from 2021 till 2027 with 2020 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America API market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.
Based on Synthesis, the North America market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
Synthetic API
• Branded Synthetic API
• Generic Synthetic API
Biotech API by Drug Type:
• Monoclonal Antibodies
• Recombinant Proteins
• Vaccines
• Other Biotech APIs
Biotech API by Customer Base:
• Innovative Biologic API
• Generic Biosimilar API
Biotech API by Expression Technology:
• Mammalian Expression
• Microbial Expression
• Yeast Expression
• Insect Expression
• Other Expression Technologies
HPAPI
• Branded HPAPI
• Generic HPAPI
Based on Manufacturing Process, the North America market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
Captive Manufacturing
• Branded Captive API
• Generic Captive API
Merchant Manufacturing by Drug Type:
• Branded Merchant API
• Generic Merchant API
Merchant Manufacturing by Drug Synthesis:
• Merchant Synthetic API
• Merchant Biotech API
Based on Therapeutic Application, the North America market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Pulmonary Disorders
• Orthopedics
• Other Applications
Based on Drug Type, the North America market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
• Branded Prescription Drugs
• Generic Prescription Drugs
• OTC Drugs
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue are available for 2017-2027. The breakdown of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America API market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter’s Fiver Forces Analysis 39
3 Segmentation of North America Market by Synthesis 43
3.1 Market Overview by Synthesis 43
3.2 Synthetic API 45
3.2.1 Branded Synthetic API 46
3.2.2 Generic Synthetic API 47
3.3 Biotech API 48
3.3.1 Biotech API by Drug Type 49
3.3.1.1 Monoclonal Antibodies 50
3.3.1.2 Recombinant Proteins 51
3.3.1.3 Vaccines 52
3.3.1.4 Other Biotech APIs 53
3.3.2 Biotech API by Customer Base 54
3.3.2.1 Innovative Biologic API 55
3.3.2.2 Generic Biosimilar API 56
3.3.3 Biotech API by Expression Technology 57
3.3.3.1 Mammalian Expression 58
3.3.3.2 Microbial Expression 59
3.3.3.3 Yeast Expression 60
3.3.3.4 Insect Expression 61
3.3.3.5 Other Expression Technologies 62
3.4 HPAPI 63
3.4.1 Branded HPAPI 64
3.4.2 Generic HPAPI 65
4 Segmentation of North America Market by Manufacturing Process 66
4.1 Market Overview by Manufacturing Process 66
4.2 Captive Manufacturing 68
4.2.1 Branded Captive API 69
4.2.2 Generic Captive API 70
4.3 Merchant Manufacturing 71
4.3.1 Merchant Manufacturing by Drug Type 72
4.3.1.1 Branded Merchant API 73
4.3.1.2 Generic Merchant API 74
4.3.2 Merchant Manufacturing by Drug Synthesis 75
4.3.2.1 Merchant Synthetic API 76
4.3.2.2 Merchant Biotech API 77
5 Segmentation of North America Market by Therapeutic Application 78
5.1 Market Overview by Therapeutic Application 78
5.2 Infectious Diseases 80
5.3 Oncology 81
5.4 Ophthalmology 82
5.5 Cardiovascular Disorders 83
5.6 Central Nervous System 84
5.7 Pulmonary Disorders 85
5.8 Orthopedics 86
5.9 Other Applications 87
6 Segmentation of North America Market by Drug Type 88
6.1 Market Overview by Drug Type 88
6.2 Branded Prescription Drugs 90
6.3 Generic Prescription Drugs 91
6.4 OTC Drugs 92
7 North America Market 2020-2027 by Country 93
7.1 Overview of North America Market 93
7.2 U.S. 96
7.3 Canada 100
7.4 Mexico 102
8 Competitive Landscape 104
8.1 Overview of Key Vendors 104
8.2 New Product Launch, Partnership, Investment, and M&A 107
8.3 Company Profiles 108
AbbVie Inc. 108
Astrazeneca 110
Aurobindo Pharma Ltd. 113
BASF 115
Bayer AG 118
Boehringer Ingelheim 120
Dr. Reddy's Laboratories 124
F. Hoffmann-La Roche 126
GlaxoSmithKline plc 128
Lonza Group 132
Lupin Limited 136
Merck & Co., Inc. 138
Mylan NV 140
Novartis International AG 142
Pfizer Inc. 144
Sanofi 148
Sun Pharmaceutical Industries Ltd. 150
Teva Pharmaceutical Industries Ltd. 152
9 Investing in North America Market: Risk Assessment and Management 155
9.1 Risk Evaluation of North America Market 155
9.2 Critical Success Factors (CSFs) 158
Related Reports and Products 161
Key Players (this may not be a complete list and extra companies can be added upon request):
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
*If Applicable.
